COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1668: Articles 16671-16680  | Next

Detecting Pathogen-Associated RNA via Piecewise Isothermal Testing achieving Sample-to-Result Integration
Banerjee, S., Biswas, S. K., Kedia, N., Sarkar, R., De, A., Mitra, S., Roy, S., Bandopadhyay, A., Banerjee, I., Goswami, R., Dutta, S., Chawla-Sarkar, M., Chakraborty, S., Mondal, A.
10.1101/2021.04.06.21254740 — Posted: 2021-04-09
Results Availability and Timeliness of Registered COVID-19 Clinical Trials: A Cross-Sectional Study
Salholz-Hillel, M., Grabitz, P., Pugh-Jones, M., Strech, D., DeVito, N. J.
10.1101/2021.04.07.21255071 — Posted: 2021-04-09
Reduction in the 2020 Life Expectancy in Brazil after COVID-19
Castro, M. C., Gurzenda, S., Turra, C. M., Kim, S., Andrasfay, T., Goldman, N.
10.1101/2021.04.06.21255013 — Posted: 2021-04-09
Reopening Italy's Schools in September 2020: A Bayesian Estimation of the Change in the Growth Rate of New SARS-CoV-2 Cases
Casini, L., Roccetti, M.
10.1101/2021.04.06.21254993 — Posted: 2021-04-09 Discussion: Onsite
Behavioural responses to Covid-19 health certification: A rapid review
Drury, J., Mao, G., John, A., Kamal, A., Rubin, J., Stott, C., Vandrevala, T., Marteau, T.
10.1101/2021.04.07.21255072 — Posted: 2021-04-09
Neighbourhood characteristics associated with the geographic variation in laboratory confirmed COVID-19 in Ontario, Canada: a multilevel analysis
Watson, T., Kwong, J. C., Kornas, K., Mishra, S., Rosella, L. C.
10.1101/2021.04.06.21254988 — Posted: 2021-04-09
The demographic and geographic impact of the COVID pandemic in Bulgaria and Eastern Europe in 2020
Rangachev, A., Marinov, G., Mladenov, M.
10.1101/2021.04.06.21254958 — Posted: 2021-04-09
An extended SEIARD model for COVID-19 vaccination in Mexico: analysis and forecast
Perez, A. G. C., Oluyori, D. A.
10.1101/2021.04.06.21255039 — Posted: 2021-04-09
Prevalence of SARS-CoV-2 antibodies in Denmark: Nationwide, population-based seroepidemiological surveys
Espenhain, L., Tribler, S., Joergensen, C. S., Holm Hansen, C., Wolf Sonksen, U., Ethelberg, S.
10.1101/2021.04.07.21254703 — Posted: 2021-04-09
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leschinsky, M., Ken Dror, S., Bergerzon, G., Gadban, H., Gadban, F., Eliassian, E., Shimron, O., Saleh, L., Ben-Zvi, H., Amichay, D., Ben-Dor, A., Sagas, D., Strauss, M., Shemer Avni, Y., Huppert, A., Kepten, E., Balicer, R. D., Nezer, D., Ben-Shachar, S., Stern, A.
10.1101/2021.04.06.21254882 — Posted: 2021-04-09 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).